Mark experiences anxiety and depression. But it was his ADHD diagnosis, at the age of 41, that helped him understand his own mind most. He tells us more...
This study identified disruption in interhemispheric circuitry (i.e., fractional anisotropy alterations in the corpus callosum) as a shared feature of ASD, ADHD, and OCD. However, fractional anisotropy alterations may be more widespread and severe in ASD and ADHD than in OCD. Higher fractional anisotropy throughout the brain appears to be related to better adaptive function across NDDs. Login using your SSSFT NHS OpenAthens for full text. SSOTP - You can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
Neuropsychology (May 16, 2019). DOI:10.1037/neu0000562
Objective: Deficits in the ability to perceive time have been proposed as an etiologic mechanism in the development of the cognitive and behavioral characteristics associated with ADHD. However, previous studies testing the presence of timing deficits have produced idiosyncratic results. This is in large part due to the underutilization of insights from basic timing research, and from the inherent difficulty that arises when a single index of performance (i.e., reaction time [RT] or accuracy) is used to index the health of what is essentially a multiple-component process. The current article utilizes a diffusion model approach to isolate the component processes involved in timing (i.e., internal clock speed, decision-making speed, speed/accuracy trade-off strategies, and nondecision time) using a well-validated timing task.. To read the full article, log in using your NHS OpenAthens details.
Attention Deficit Hyperactivity Disorder (ADHD) in children across the UK. A look at its impact and what must be done to achieve equity for these particularly vulnerable children, so they might be able to reach their exceptional potential as they progress into adulthood.
Open access. Attention-Deficit/Hyperactivity Disorder (ADHD) has a significant impact on child and adolescent development, especially in relation to school functioning and academic outcomes. Despite the transition to high school being a potentially critical period for children with ADHD, most research in this period has focused on academic outcomes. This study aims to extend previous research by describing academic, school engagement, behaviour and social-emotional outcomes for young people with ADHD in the first and third years of high school and to identify risk and protective factors predictive of differing outcomes across these four domains.
Psychological Assessment (Oct 25, 2018). DOI:10.1037/pas0000659
This meta-analysis compares stand-alone and embedded performance and symptom validity tests (PVTs and SVTs) for attention-deficit/hyperactivity disorder (ADHD) malingering detection in college students. Simulation design studies utilizing college student samples were included (k = 11). Analyses consisted of measures designed or previously used for malingering detection.. To read the full article, log in using your NHS OpenAthens details.
Attention-deficit/hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD) are frequently co-occurring in youth, but data about the pharmacological management of this comorbidity are scarce, especially when impulsive aggression is prominent. Although stimulants are the first-line medication for ADHD, second-generation antipsychotics, namely, risperidone, are frequently used. We aimed to assess effectiveness and safety of monotherapy with the stimulant methylphenidate (MPH) and risperidone in a consecutive sample of 40 drug-naive male youths diagnosed as having ADHD-combined presentation, comorbid with ODD and aggression, without psychiatric comorbidities, according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria and a structured clinical interview (Schedule for Affective Disorders and Schizophrenia for School-Age Children—Present and Lifetime Version). SSSFT staff can use the OVID link, or you can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
Academic impairment is among the most troubling domains of impairment for adolescents with Attention Deficit/Hyperactivity Disorder (ADHD). Login using your SSSFT NHS OpenAthens for full text. SSOTP - request a copy of the article from the library - http://bit.ly/1Xyazai
Letter. Login at top right hand side of page using your SSSFT NHS OpenAthens for full text. SSOTP- Please contact the library to receive a copy of this article - http://bit.ly/1Xyazai
Attention deficit hyperactivity disorder (ADHD) is a condition characterised by inattentiveness, hyperactivity and impulsivity, according to the ADHD Foundation. Most young people with a sustained diagnosis will go on to have significant difficulties in adulthood, which may include continued ADHD, personality disorders, emotional and social difficulties, substance misuse, unemployment and involvement in crime (NICE 2008). Some people tend to be mainly hyperactive and impulsive, while others are principally inattentive. Symptoms of ADHD are distributed throughout the population and vary in severity. Only those with significant impairment meet criteria for a diagnosis of ADHD. Research suggests it affects about 5% of children. To read the full article, log in using your NHS Athens
Using drugs to treat children with attention deficit hyperactivity disorder (ADHD) may have reached a plateau, after a steep rise in prescriptions over the past 18 years. To read the full article, log in using your NHS OpenAthens details
Research News. People with attention deficit hyperactivity disorder (ADHD) had a lower risk of motor vehicle crashes when they had received their medication, research published in JAMA Psychiatry shows.
To read the full article, log in using your NHS OpenAthens details
Attention-deficit hyperactivity disorder (ADHD) is a common childhood behavioural disorder. Systematic reviews indicate that the community prevalence globally is between 2% and 7%, with an average of around 5%. At least a further 5% of children have substantial difficulties with overactivity, inattention, and impulsivity that are just under the threshold to meet full diagnostic criteria for ADHD. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
Nurses need training to support children and their parents to manage attention deficit hyperactivity disorder (ADHD) following a diagnosis, says the head of an advocacy group. To read the full article, log in using your MPFT NHS OpenAthens details.
Substance use disorders are major contributors to excess mortality among individuals with attention deficit hyperactivity disorder (ADHD), yet associations between pharmacological ADHD treatment and substance-related problems remain unclear. This study investigated concurrent and long-term associations between ADHD medication treatment and substance-related events. Login at top right hand side of page using your SSSFT NHS Athens for full text.
Child psychiatric treatment facilities vary greatly worldwide and are virtually non-existent in many low-income countries. One of the most common psychiatric disorders in childhood is ADHD, with an estimated prevalence of 3–5% in Sweden. Previous studies have shown a similar prevalence of ADHD in minority and majority children in Sweden and the UK. However, clinical studies demonstrated that children from immigrant families living in Sweden received less psychiatric care than those of native-born parents. We tested the hypothesis that the consumption of child psychiatric care in immigrant families would be determined by the availability of such treatment in the parents’ country of origin. Patterns of medication for attention-deficit hyperactivity disorder (ADHD) were studied as a proxy for child psychiatric care.
Chris Hollis and colleagues' Article1 in The Lancet Psychiatry has many strengths. It addresses an important clinical question: does methylphenidate treatment for ADHD increase the risk of psychosis in patients with and without previous psychotic symptoms. Hollis and colleagues used Swedish national registers to review a large number (n=23 898) of health records, to examine the incidence of psychotic symptoms 12 weeks before, 12 weeks after, and 1 year after starting medication treatment, with a longitudinal within-subject study design. Their results indicated that methylphenidate treatment for ADHD does not increase psychotic symptoms in the short-term or long-term in patients with and without previous psychosis. There is some suggestion in their study that methylphenidate might, in fact, decrease the risk of a psychotic episode, particularly in patients with a history of psychosis. The findings of their study should therefore be reassuring to clinicians. However, as the authors themselves point out, the study has several limitations that could affect the reassuring message.. Please contact the library to request a copy of this article - http://bit.ly/2HjNDf3
...a newly published study from the University of California at Berkeley focuses on girls with the condition, showing many of the same unfortunate results. Visible symptoms of hyperactivity and restlessness largely recede during adolescence, but the girls
...a newly published study from the University of California at Berkeley focuses on girls with the condition, showing many of the same unfortunate results. Visible symptoms of hyperactivity and restlessness largely recede during adolescence, but the girls
Essential facts: Attention deficit hyperactivity disorder (ADHD) is a group of behavioural symptoms including hyperactivity, impulsivity and inattention. Symptoms tend to be noticed at an early age and most cases are diagnosed when children are 6-12 years old. You can request a copy of this article by replying to this email. Please ensure you are clear which article you are requesting.
Methylphenidate is the most effective and safest short term drug treatment for children with attention-deficit hyperactivity disorder (ADHD), while amphetamines are most effective in adults, a major analysis has found. To read the full article, log in using your NHS OpenAthens details.
Accounts of use for depression, ADD/ADHD, fibromyalgia, chronic fatigue (off-label). Metabolic precursor to modafinil; takes 1 hr to kick in, hard on liver. Not "controlled" like modafinil/Provigil.
Unlike conventional stimulants, no anxiety, agitation and insomnia; selectively stimulates brain's adrenergic receptors for norepinephrine (noradrenaline), a neurotransmitter linked to alertness, learning, and memory.
For narcolepsy, or off-label for depression, night-shift work, ADHD/ADD...a prodrug, metabolizes to modafinil (Provigil®), resulting in nearly identical pharmacological effects, takes 45-60 minutes to reach active levels in bloodstream.
Attention-deficit/hyperactivity disorder (ADHD) in the adult population is frequently associated with comorbid psychiatric diseases that complicate its recognition, diagnosis and management.
The prevalence of ADHD in the general adult population is 2.5% and it is associated with substantial personal and individual burden. The most frequent comorbid psychopathologies include mood and anxiety disorders, substance use disorders, and personality disorders. There are strong familial links and neurobiological similarities between ADHD and the various associated psychiatric comorbidities. The overlapping symptoms between ADHD and comorbid psychopathologies represent challenges for diagnosis and treatment. Guidelines recommend that when ADHD coexists with other psychopathologies in adults, the most impairing condition should generally be treated first.
Early recognition and treatment of ADHD and its comorbidities has the potential to change the trajectory of psychiatric morbidity later in life. The use of validated assessment scales and high-yield clinical questions can help identify adults with ADHD who could potentially benefit from evidence-based management strategies.
Professional Psychology: Research and Practice Vol. 48, Iss. 6, (Dec 2017): 438-444.
Initial diagnoses of ADHD in adulthood have increased tremendously in recent years. Making such diagnoses accurately is challenging because ADHD is a childhood-onset disorder and because many adults have an incentive for obtaining a diagnosis (e.g., access to stimulant medication or disability accommodations). Certain elements of a forensic perspective can lead to more accurate ADHD diagnoses in adults and targeted treatment for clients who genuinely need it, and more appropriate alternative clinical responses to those who do not. This article describes the research base for integrating forensic principles into clinical assessments of adults presenting with ADHD-related concerns, and provides a scientific model for such assessments, from referral through conclusions. (PsycINFO Database Record (c) 2017 APA, all rights reserved) (Source: journal abstract)
A letter to the editor is presented in response to the article "Is adult attention-deficit hyperactivity disorder being overdiagnosed?," by Joel Paris, V. Bhat, and B. Thombs in the 2015 issue. Login using your SSSFT NHS OpenAthens for full text. SSOTP - request a copy of the article from the library - www.sssft.nhs.uk/library
A letter to the editor is presented in response to the article "Is adult attention-deficit hyperactivity disorder being overdiagnosed?," by Joel Paris, V. Bhat, and B. Thombs in the 2015 issue. Login using your SSSFT NHS OpenAthens for full text. SSOTP - request a copy of the article from the library - www.sssft.nhs.uk/library
For many years, attention-deficit hyperactivity disorder (ADHD) was thought to be a childhood-onset disorder that has a limited effect on adult psychopathology. However, the symptoms and impairments that define ADHD often affect the adult population, with similar responses to drugs such as methylphenidate, dexamphetamine, and atomoxetine, and psychosocial interventions, to those seen in children and adolescents. As a result, awareness of ADHD in adults has rapidly increased and new clinical practice has emerged across the world. Despite this progress, treatment of adult ADHD in Europe and many other regions of the world is not yet common practice, and diagnostic services are often unavailable or restricted to a few specialist centres. Please contact the library to receive a copy of this article - http://bit.ly/1Xyazai
Practice Innovations 1.1 (Mar 2016): 36-52.
A common problem in the treatment of attention-deficit/hyperactivity disorder (ADHD) is that, in addition to the myriad of functional impairments reported by clinic-referred adults, the disorder itself interferes with follow-through on and effective use of treatment recommendations, particularly the coping skills that are central to effective management of ADHD. In fact, adults with ADHD will often state that the crux of their frustrations is that they know what they need to do but are nonetheless unable to turn their intentions into actions. Existing diagnostic criteria do not fully capture the underlying problems related to the self-regulation and motivational deficits experienced by patients that result in these performance problems, nor do these criteria sufficiently inform psychosocial treatment. To read the full article, log in using your NHS OpenAthens details
M. Weisskopf. (2010)http://www.talyarkoni.org/blog/2010/05/18/a-possible-link-between-pesticides-and-adhd/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+citationNeeded+%28%5Bcitation+needed%5D%29.